Skip to main content
. Author manuscript; available in PMC: 2017 Mar 14.
Published in final edited form as: Vaccine. 2016 Feb 10;34(12):1452–1458. doi: 10.1016/j.vaccine.2016.01.064

Figure 2.

Figure 2

Serum norovirus-specific IgG1 and IgG2 production following intranasal immunization with GelVac vaccine powders. Serum samples described in Figure 5 were pooled for each group and analyzed for GI (A) and GII.4 (B) norovirus-specific IgG1 and IgG2 antibodies.